PRKD1 and neoplasm: Interestingly, the percentage of positive cells for PRKD1 promoter methylation was found to be significantly increased in the most aggressive types of breast cancer, including triple-negative cancer, and, in IDC cases, gradually increased lymph nodes positive for tumor cells as well as lymph node metastases.